Affimed N.V. (AFMD)
NASDAQ: AFMD · Real-Time Price · USD
2.720
-0.280 (-9.33%)
At close: Nov 20, 2024, 4:00 PM
2.700
-0.020 (-0.74%)
Pre-market: Nov 21, 2024, 6:13 AM EST
Affimed Revenue
Affimed had revenue of 164.00K EUR in the quarter ending September 30, 2024, a decrease of -91.62%. This brings the company's revenue in the last twelve months to 5.64M, down -72.92% year-over-year. In the year 2023, Affimed had annual revenue of 13.91M, down -67.39%.
Revenue (ttm)
5.64M EUR
Revenue Growth
-72.92%
P/S Ratio
6.66
Revenue / Employee
74,171 EUR
Employees
76
Market Cap
42.65M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 13.91M | -28.76M | -67.39% |
Dec 31, 2022 | 42.67M | 1.12M | 2.70% |
Dec 31, 2021 | 41.55M | 12.69M | 43.99% |
Dec 31, 2020 | 28.86M | 7.43M | 34.66% |
Dec 31, 2019 | 21.43M | -2.30M | -9.68% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cytosorbents | 37.74M |
BGM Group | 29.87M |
Kronos Bio | 9.87M |
Milestone Scientific | 8.88M |
Lucid Diagnostics | 4.19M |
vTv Therapeutics | 1.00M |
CollPlant Biotechnologies | 689.00K |
AFMD News
- 6 days ago - Affimed N.V. (AFMD) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Affimed Reports Third Quarter 2024 Financial Results & Business Update - GlobeNewsWire
- 15 days ago - Affimed to Report Third Quarter 2024 Financial Results & Corporate Update on November 14, 2024 - GlobeNewsWire
- 2 months ago - Affimed to Present at the Cantor Global Healthcare Conference 2024 - GlobeNewsWire
- 2 months ago - Affimed N.V. (AFMD) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Affimed Reports Second Quarter 2024 Financial Results & Business Update - GlobeNewsWire
- 2 months ago - Affimed Follow Up: Upcoming Acimtamig And AFM24 Updates Could Be Positive Catalysts - Seeking Alpha
- 2 months ago - Affimed Appoints Shawn M. Leland as Chief Executive Officer - GlobeNewsWire